Skip to main content
. 2012 May 23;2:12. doi: 10.1186/2110-5820-2-12

Table 1.

Analysis Comparing Pre- and Post-Dexmedetomidine Data

Endpoint Sample size (n) for endpoint 24 h before dex First 24 H of dex therapy Decrease in values following dex initiation (percent decrease) pvalue 95% Confidence interval for decrease seen after dex initiation
Average Alcohol Withdrawal Scoring
11
9.0
7.1
1.9 (21.1%)
0.015
0.44–3.36(4.9%–37.3%)
Average Benzodiazepines Received (mg)
17
52.7
20.3
32.4 (61.5%)
<0.001
16.7–48.1(31.7%–91.3%)
Average Haloperidol Received (mg)
17
12.0
6.4
5.6 (46.7%)
0.052
0.03–11.23(−0.36–93.6%)
Average HR
17
102.8
79.3
23.4 (22.8%)
<0.001
18.4–28.4(17.9%–27.6%)
Average SBP
17
140.2
126.7
13.5 (9.6%)
0.002
5.32–21.68(3.8%–15.4%)
Hours With HR > 100
16
13.3
2.3
10.9 (82.0%)
<0.001
7.4–14.4(55.6–108.3%)
Hours With SBP >140
16
11.0
6.3
4.7 (42.3%)
0.02
0.8–8.6(3.8–15.4%)
Hours With HR <60
16
0.0
2.0
−2.0
0.055
4.05–0.05
Hours With SBP <90 16 0.0 0.9 −0.9 0.079 1.89–0.09

For dosing, total dose per 24 h period for each patient was averaged. For average vitals, mean values per 24 h period for each patient were averaged. For vitals outside normal range, total time outside normal range was calculated for each patient per 24 h period, and averaged. A sample size of 16 (instead of 17) was used for analyses of time spent with vitals outside normal, due to one patient having only six hours of available data. P values obtained from two-tailed paired t-tests. 95% confidence interval was calculated using t distribution for a paired sample and n-1 degrees of freedom. Dex = dexmedetomidine; SBP = systolic blood pressure; HR = heart rate.